Revenue estimates for Standard BioTools Inc (NASDAQ:LAB) have remained steady at $171.20 million for the full year 2024. However, they have declined from $188.17 million to $186.93 million for 2025 ...
We came across a bullish thesis on Astera Labs, Inc. on Mark Meldrum’s YouTube Channel. In this article, we will summarize ...
LAB is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of LAB shares has held flat since the market last closed. This is a 0.00% change.
Good day and welcome to the Standard BioTools Inc. First Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, today's event is ...
Rocket Lab USA, Inc. (RKLB) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago. These figures ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EAG, Inc. (Evans Analytical Group), the world’s leading, fully integrated, independent laboratory network, providing high value expert analytical and testing ...
Rocket Lab USA, Inc. (RKLB) closed the latest trading day at $7.17, indicating a +0.7% change from the previous session's end. The stock's performance was behind the S&P 500's daily gain of 1.7%.
Standard BioTools Inc (NASDAQ:LAB) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $40.10 million, and the earnings are expected to come in at ...
Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback